Vanguard Group’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $130K | Hold |
|
|||||
2025
Q1 | $146K | Hold |
|
|||||
2024
Q4 | $138K | Buy |
|
|||||
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $51.1K | Buy |
|
|||||
2023
Q1 | – | Sell |
|
|||||
2022
Q4 | $19.4K | Hold |
|
|||||
2022
Q3 | $30K | Sell |
|
|||||
2022
Q2 | $108K | Hold |
|
|||||
2022
Q1 | $290K | Sell |
|
|||||
2021
Q4 | $374K | Sell |
|
|||||
2021
Q3 | $642K | Buy |
|
|||||
2021
Q2 | $742K | Buy |
|
|||||
2021
Q1 | $338K | Buy |
|
|||||
2020
Q4 | $99K | Buy |
|
|||||
2020
Q3 | $61K | Buy |
|
|||||
2020
Q2 | $11K | Hold |
|
|||||
2020
Q1 | $7K | Hold |
|
|||||
2019
Q4 | $17K | Hold |
|
|||||
2019
Q3 | $15K | Hold |
|
|||||
2019
Q2 | $17K | Hold |
|
|||||
2019
Q1 | $25K | Hold |
|
|||||
2018
Q4 | $15K | Hold |
|
|||||
2018
Q3 | $65K | Hold |
|
|||||
2018
Q2 | $78K | Hold |
|
|||||
2018
Q1 | $70K | Buy |
|
|||||
2017
Q4 | – | Sell |
|
|||||
2017
Q3 | $193K | Sell |
|
|||||
2017
Q2 | $751K | Sell |
|
|||||
2017
Q1 | $658K | Buy |
|
|||||
2016
Q4 | $1.78M | Sell |
|
|||||
2016
Q3 | $2.24M | Hold |
|
|||||
2016
Q2 | $2.49M | Sell |
|
|||||
2016
Q1 | $2.02M | Hold |
|
|||||
2015
Q4 | $3.22M | Hold |
|
|||||
2015
Q3 | $2.96M | Buy |
|
|||||
2015
Q2 | $3.6M | Hold |
|
|||||
2015
Q1 | $3.15M | Hold |
|
|||||
2014
Q4 | $3.65M | Buy |
|
|||||
2014
Q3 | $1.29M | Buy |
|
|||||
2014
Q2 | $404K | Buy |
|
|||||
2014
Q1 | $279K | Buy |
|